Ciclopirox (Taro Pharmaceuticals U.S.A., Inc.)
Welcome to the PulseAid listing for the Ciclopirox drug offered from Taro Pharmaceuticals U.S.A., Inc.. This Decreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Taro Pharmaceuticals U.S.A., Inc. |
| NON-PROPRIETARY NAME: | Ciclopirox |
| SUBSTANCE NAME: | CICLOPIROX OLAMINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | SUSPENSION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2005-08-10 |
| END MARKETING DATE: | 0000-00-00 |
Ciclopirox HUMAN PRESCRIPTION DRUG Details:
| Item Description | Ciclopirox from Taro Pharmaceuticals U.S.A., Inc. |
| LABELER NAME: | Taro Pharmaceuticals U.S.A., Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 7.7(mg/mL) |
| START MARKETING DATE: | 2005-08-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51672-1323_055fcd4a-e5a2-4856-a9e1-e6dd2b22d28e |
| PRODUCT NDC: | 51672-1323 |
| APPLICATION NUMBER: | ANDA077092 |
Other CICLOPIROX OLAMINE Pharmaceutical Manufacturers / Labelers:
